De Ying Cao
Direktor/Vorstandsmitglied bei HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Aktive Positionen von De Ying Cao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 30.12.2021 | - |
| Independent Dir/Board Member | 30.12.2021 | - | |
| Hebei Medical University | Corporate Officer/Principal | 08.08.2011 | - |
Hebei Yipin Pharmaceutical Co., Ltd.
 Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Direktor/Vorstandsmitglied | 01.05.2021 | - |
| Independent Dir/Board Member | 01.05.2021 | - |
Karriereverlauf von De Ying Cao
Ehemalige bekannte Positionen von De Ying Cao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 08.08.2011 | - |
| Independent Dir/Board Member | 08.08.2011 | - |
Statistik
International
| China | 4 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
- Börse
- Insiders
- De Ying Cao
- Erfahrung
